American Bio Medica

American Bio Medica EBITDA per Employee

Delisted

The EBITDA per Employee of American Bio Medica (ABMC) as of Nov 20, 2026 is -15,721.52 USD. In the previous year, EBITDA per Employee was -14,924.05 USD — a change of 5.34% (lower).

EBITDA per Employee

-15,721.52USD

YoY

5.34%

Last updated:

EBITDA per Employee of American Bio Medica is 2022 -15,721.52 USD. EBITDA per Employee of American Bio Medica was 2021 -14,924.05 USD. It decreases by 5.34% lower compared to the previous year.

The American Bio Medica EBITDA per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Employee
Date
EBITDA per Employee
Jan 1, 2015
-164.56 USD
Jan 1, 2016
-3,253.16 USD
Jan 1, 2017
-3,936.71 USD
Jan 1, 2018
-9,645.57 USD
Jan 1, 2019
-7,506.33 USD
Jan 1, 2020
-7,860.76 USD
Jan 1, 2021
-14,924.05 USD
Jan 1, 2022
-15,721.52 USD
The American Bio Medica EBITDA per Employee history
YEAREBITDA per EmployeeYoY
-15,721.52USD+5.34%
-14,924.05USD+89.86%
-7,860.76USD+4.72%
-7,506.33USD-22.18%
-9,645.57USD+145.02%
-3,936.71USD+21.01%
-3,253.16USD+1,876.92%
-164.56USD-94.01%
-2,746.84USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

American Bio Medica Stock analysis

What does American Bio Medica do? American Bio Medica Corp is a US-based company specializing in the development and manufacture of drug testing devices and diagnostic products. The company was founded in 1986 and is headquartered in Kinderhook, New York. Its business model involves developing and producing drug testing devices and diagnostic products used by government agencies, companies, and private customers worldwide. The company also operates a laboratory that conducts diagnostic tests for third parties. Its five business areas include drug tests, medication safety, diagnostics, biometrics, and forensics. The company's products include urine, saliva, and sweat drug tests, as well as medical devices to prevent prescription drug abuse and diagnostic products for various diseases. It also offers biometric instruments and systems for person identification and forensic products for crime investigation. American Bio Medica Corp has been publicly traded since 1992 and has received several awards for its products and innovations. The company is committed to research and development, quality assurance, and accuracy in its products. Overall, it is a leading company in the field of drug testing devices and diagnostic products and is expected to continue to evolve in the future. American Bio Medica is one of the most popular companies on Eulerpool.

Frequently Asked Questions about American Bio Medica stock

EBITDA per Employee of American Bio Medica is -15,721.52 USD in 2022.

EBITDA per Employee of American Bio Medica changed from -14,924.05 USD to -15,721.52 USD, representing a 5.34% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Employee American Bio Medica since 2006 – with annual values, charts, and detailed analysis.

EBITDA per employee measures operating cash earnings generated per employee, showing workforce productivity before depreciation and financing effects.

EBITDA per Employee's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA per Employee's American Bio Medica historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — American Bio Medica

All Key Metrics — American Bio Medica